Article

Easing the Economic and Clinical Burden of Psoriasis and Psoriatic Arthritis: The Role of Managed Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
April Armstrong, MD, MPH, chief of dermatology, UCLA
April Armstrong, MD, MPH, chief of dermatology, UCLA
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Cente
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center
Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1
Joseph Zabinksi, PhD, MEM, vice president, head of commercial strategy and AI, OM1
Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Related Content
Adalimumab | Image credit: luchschenF - stock.adobe.com
June 16th 2025

Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

Pearl Steinzor
Target trial emulation study finds no added effectiveness or persistence with combination therapy for plaque psoriasis.
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
August 3rd 2021

Psoriasis as an Inflammatory Disease, and What’s Changed Over Time

August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.
Psoriasis skin, eczema, rash and other skin diseases. | Image credit: stockmaster - stock.adobe.com.jpg
June 3rd 2025

Patients With GPP Face Elevated Mortality Risk, Study Finds

Pearl Steinzor
US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared with the general population.
woman with psoriasis | Image credit: Andrey Popov - stock.adobe.com
May 29th 2025

Biosimilar Starjemza Gains FDA Approval as Ustekinumab Shows Significant Psoriasis-Itch Relief

Giuliana Grossi
Ustekinumab offers superior itch relief for severe psoriasis compared with guselkumab, new data show.
Plaque psoriasis | Image credit: Milan Lipowski - stock.adobe.com
May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis

Pearl Steinzor
Once-daily roflumilast provides skin clearance and rapid itch relief with no limitation on duration of use.
Woman with psoriasis | Andrey Popov - stock.adobe.com
May 7th 2025

Clinical Severity May Not Correlate With Psychological Burden of Psoriasis, Study Finds

Pearl Steinzor
The impact of psoriasis on quality of life goes beyond clinical measures, such as psoriasis area severity index (PASI) and body surface area (BSA), a study finds.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo